A Message From The President


Rudy Nuijts
Published: Thursday, March 26, 2020
Dear Colleagues
Today we talk to our friends and ESCRS Board members in the United Kingdom.
The UK has a very large population and a very well-known healthcare system. Our colleagues have shared with us the measures that the NHS is taking to deal with this crisis. Our colleague, Paul Rosen, chairman of the board of trustees of ESCRS, reminds us that we must see the opportunity in this terrible situation. This will include people showing their leadership skills, working at the limits of their comfort zone and stretching their personal and clinical skills.
Inevitably our thoughts turn to the possibilities around convening our ESCRS Congress in October.
The ESCRS leadership is carefully monitoring the current situation. We have received over almost 2,500 abstracts for the Amsterdam Congress and continue with planning for our October meeting. Of course, we will be guided by any recommendations from the authorities as the meeting time gets closer. The safety of our delegates, sponsors and all our stakeholders are most important to us.
Any changes that may impact our upcoming congress will be posted on the ESCRS website and on social media.
As always stay safe and well.
READ THE NEWSLETTER HERE

Rudy Nuijts
Prof. dr Rudy MMA Nuijts
ESCRS President

Tags: covid-19 uk
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.